MBL2 and atrial fibrillation: While the trend of MBL concentration in AF treated with the mesenchymal stromal cells showed a significant increase only at 72 h (p < 0.05), compared to the zero time, a significant decrease at 1 week compared to AF at the same time (p < 0.05) was observed.